A - PacBio cut to Neutral at Goldman Sachs after guidance cut
2024-04-18 08:15:54 ET
More on Pacific Biosciences of California
- Pacific Biosciences' Pivot: From Shareholder Dilution To Expansion And Leadership
- Pacific Biosciences of California, Inc. (PACB) Q4 2023 Earnings Call Transcript
- Why Is Pacific Biosciences' Price Action So Bad? (Downgrade)
- PacBio falls after issuing guidance below expectations
- Pacific Biosciences of California Non-GAAP EPS of -$0.27 beats by $0.01, revenue of $58.36M in-line